Table 3.
Number of events and cells obtained, before and after cell merging, for samples used to characterize specific cell populations from healthy subjects and HIV-infected patients.
| Sample ID | Stimulation | Profile | Number of events | Number of cells | Number of excluded cells |
|---|---|---|---|---|---|
| HEA-1 | CTRL | #A | 443,527 | 237,039 | - |
| HEA-1 | CTRL | #B | 321,545 | 192,201 | - |
| HEA-1 | CTRL | #C | 245,550 | 139,218 | - |
| HEA-1 | CTRL | #A+B+C | - | 139,104 | 151,146 |
| HEA-2 | CTRL | #A | 464,263 | 249,773 | |
| HEA-2 | CTRL | #B | 463,584 | 249,003 | - |
| HEA-2 | CTRL | #C | 413,188 | 229,388 | - |
| HEA-2 | CTRL | #A+B+C | - | 229,058 | 40,990 |
| HEA-3 | CTRL | #A | 304,750 | 128,604 | - |
| HEA-3 | CTRL | #B | 243,011 | 112,246 | - |
| HEA-3 | CTRL | #C | 219,468 | 103,360 | - |
| HEA-3 | CTRL | #A+B+C | - | 103,088 | 34,946 |
| PAT-1 | CTRL | #A | 395,659 | 221,756 | - |
| PAT-1 | CTRL | #B | 275,968 | 162,754 | - |
| PAT-1 | CTRL | #C | 177,213 | 104,389 | - |
| PAT-1 | CTRL | #A+B+C | - | 103,834 | 177,397 |
| PAT-2 | CTRL | #A | 424,726 | 254,188 | - |
| PAT-2 | CTRL | #B | 380,247 | 229,615 | - |
| PAT-2 | CTRL | #C | 333,418 | 211,915 | - |
| PAT-2 | CTRL | #A+B+C | - | 211,223 | 62,049 |
| PAT-3 | CTRL | #A | 132,587 | 77,907 | - |
| PAT-3 | CTRL | #B | 108,431 | 68,757 | - |
| PAT-3 | CTRL | #C | 110,803 | 68,749 | - |
| PAT-3 | CTRL | #A+B+C | - | 67,280 | 13,573 |
The number of cells obtained for each profile before and after cells merging was indicated. The profile #A+B+C represents the combined cytometric profiles obtained by the merging of profiles #A, #B, and #C. For each combined profile, the number of cells excluded during the merging was indicated. Samples with names starting with HEA correspond to healthy subjects, and samples with names starting with PAT correspond to HIV-infected patients.